The global sterile antimicrobial gel market is projected to grow from approximately US$ 1.44 billion in 2023 to US$ 3.05 billion by 2034, with a CAGR of 7.05% from 2024 to 2034. This growth is driven by the rising demand for the gel’s use in preventing infections in chronic wounds, traumatic injuries, and post-operative care, owing to its biocompatibility and wound healing properties.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5308
In September 2024, the U.S. Department of Health and Human Services (HHS) announced funding for a project called “Transforming Antibiotic R&D with Generative AI to Stop Emerging Threats (TARGET)” through the Advanced Research Projects Agency for Health.
The G7 Finance and Health Ministers committed to implementing existing antimicrobial resistance (AMR) strategies, addressing the market failures of antibiotics, and fostering economic conditions to preserve the effectiveness of essential antibiotics.
In November 2023, the Food and Drug Administration (FDA) proposed new requirements for a premarket approval application (PMA) for certain wound dressings formulated as creams, gels, or ointments, as well as solid wound dressings and liquid wound washes containing medically important antimicrobials. These products must comply with the PMA requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act). Solid wound dressings and other antimicrobial-infused products are designed to maintain appropriate moisture levels and provide protection for wounds.
Medically essential antimicrobials are included in these dressings to minimize microbial growth and create an antimicrobial barrier against infections. Patients are the primary end users of these formulations and liquid wound washes, which are water-based solutions used to clean external wounds. The FDA assesses the benefits and risks of these antimicrobial products, considering potential adverse tissue reactions, immunological responses, pathogen transmission, delayed wound healing, and infection risks.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/sterile-antimicrobial-gel-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5308
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global single-cell biotherapeutics market is on a robust growth trajectory, with projections indicating a surge into the hundreds of… Read More
The global multiomics in drug discovery market is undergoing transformative growth, with projections pointing toward a significant surge in revenue… Read More
The global healthcare ecosystem is undergoing a profound transformation. One of the most pivotal shifts is the surge in demand… Read More
The global clinical genomics market is set to grow from USD 1.06 billion in 2024 to an impressive USD 5.34… Read More
The global AI in medical billing market is undergoing a significant transformation, poised to grow from USD 3.73 billion in… Read More
The global preclinical advanced cell models market is rapidly evolving, fueled by the increasing demand for accurate, human-relevant testing platforms… Read More